Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Vorinostat (DB02546)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00258349Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerTreatment